Related Experiment Video

Updated: Jul 5, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias

Shahriar Iravanian1, Samuel C Dudley

  • 1Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia, USA.

Heart Rhythm
|February 10, 2009
PubMed

Insights

The renin-angiotensin-aldosterone system (RAAS) contributes to cardiac arrhythmias by affecting ion channels and increasing oxidative stress. RAAS modulators show promise in preventing and treating these arrhythmias.

Area of Science:

  • Cardiovascular Science
  • Electrophysiology
  • Pharmacology

Background:

  • The renin-angiotensin-aldosterone system (RAAS) is implicated in cardiovascular diseases like hypertension and hypertrophy.
  • Its role in cardiac arrhythmias is an emerging area of research.

Purpose of the Study:

  • To review the proarrhythmic effects of RAAS on cardiac electrophysiology.
  • To explore the contribution of oxidative stress to RAAS-mediated arrhythmias.
  • To summarize ongoing clinical trials on RAAS modulators for arrhythmia management.

Main Methods:

  • Review of experimental results on RAAS effects on ion channels.
  • Analysis of the role of oxidative stress in RAAS-induced arrhythmias.
  • Compilation of data from ongoing clinical trials.

Main Results:

  • RAAS influences membrane and sarcoplasmic reticulum ion channels, potentially causing proarrhythmic effects.
  • Increased oxidative stress is a likely mechanism contributing to RAAS-related arrhythmias.
  • RAAS modulators have demonstrated a reduced incidence of certain arrhythmias.

Conclusions:

  • The RAAS plays a significant role in the development of cardiac arrhythmias.
  • Targeting RAAS with modulators may be a viable strategy for arrhythmia prevention and treatment.
  • Further clinical trials are needed to confirm the therapeutic utility of RAAS modulators in arrhythmias.

More Related Videos

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...